Evidence map›Paper›PMID 36861057›Full record

ArticleInternational journal of clinical practice2023

Nigelladine A among Selected Compounds from

Md Mehedy Hasan Miraz, Md Afif Ullah, Abdullah Al Nayem, Brototi Chakrobortty, Sanjoy Deb, Anee Laskar, Nishita Umaya Tithi, Nilay Saha, Anita Rani Chowdhury, K M Khairul Alam and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of clinical practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Key ingredients inFrontiers in plant science · 2023
    Article
  3. Mechanistic insight ofFrontiers in chemistry · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Md Mehedy Hasan MirazDepartment of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.ORCID https://orcid.org/0000-0002-1566-2272
Md Afif UllahDepartment of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.
Abdullah Al NayemDepartment of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.
Brototi ChakroborttyDepartment of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.
Sanjoy DebDepartment of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.
Anee LaskarDepartment of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.
Nishita Umaya TithiDepartment of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.
Nilay SahaDepartment of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.
Anita Rani ChowdhuryDepartment of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.ORCID https://orcid.org/0000-0002-7956-169X
K M Khairul AlamDepartment of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.
Tania Binte WahedDepartment of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.
Mohammad Khursheed AlamPreventive Dentistry Department, Orthodontic Division, College of Dentistry, Jouf University, Sakaka 72345, Saudi Arabia.ORCID https://orcid.org/0000-0001-7131-1752
Sukalyan Kumar KunduDepartment of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.ORCID https://orcid.org/0000-0002-5130-7163
Jahangirnagar University · BDJagannath University · BDJouf University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 has been a threat to the entire world for more than two years since its outbreak in December 2019 in Wuhan city of China. SARS-CoV-2, the causative agent, had been reported to mutate over time exposing new variants. To date, no impeccable cure for the disease has been unveiled. This study outlines an extensive in silico approach to scrutinize certain phytochemical compounds of

Indexed as

COVID-19Nigella sativaDiterpenesHumansMolecular Docking SimulationSARS-CoV-2Diterpenesnigelladine A

Identifiers

PMID36861057
PMCPMC9970708
OpenAlexW4321378248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.